INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 72 filers reported holding INSTIL BIO INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $51,608 | +4.9% | 78,100 | 0.0% | 0.00% | – |
Q4 2022 | $49,203 | -95.0% | 78,100 | -61.6% | 0.00% | – |
Q3 2022 | $985,000 | +9.3% | 203,580 | +4.4% | 0.00% | – |
Q2 2022 | $901,000 | -97.3% | 194,980 | -93.8% | 0.00% | -100.0% |
Q1 2022 | $33,908,000 | -35.2% | 3,154,270 | +3.2% | 0.01% | -27.8% |
Q4 2021 | $52,319,000 | +3.3% | 3,057,792 | +7.9% | 0.02% | -10.0% |
Q3 2021 | $50,653,000 | -8.0% | 2,833,725 | -0.6% | 0.02% | -9.1% |
Q2 2021 | $55,063,000 | +8.6% | 2,850,049 | +41.0% | 0.02% | 0.0% |
Q1 2021 | $50,705,000 | – | 2,021,728 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |